谷氨酰胺合成酶缺陷活减毒寄生虫免疫诱导记忆T细胞分化保护宿主抵抗杜氏利什曼原虫强毒感染
本研究报道一株代谢缺陷的谷氨酰胺合成酶双敲除杜氏利什曼原虫活减毒株(LdGS-/-),以极低接种量单剂免疫BALB/c小鼠后,在强毒攻击后早至2周即诱导IFN-γ+ Th1介导免疫,并促进脾脏CD4+ T效应与记忆细胞分化,提供基于长寿命记忆细胞的保护;攻击后第8周记忆相关细胞因子表达仍较高。
要点
- LdGS-/-活减毒株单剂极低接种量即可在强毒攻击后2周诱导IFN-γ+ Th1免疫。
- 免疫后小鼠脾脏CD4+ T效应与记忆细胞分化,提供针对野生型杜氏利什曼原虫的长期记忆保护。
- 攻击后第8周促炎与记忆维持细胞因子表达仍高于对照,提示LdGS-/-为潜在活减毒疫苗候选。
核心结论
- LdGS-/-寄生虫是设计针对杜氏利什曼原虫强毒感染的潜在活减毒疫苗候选株的新颖且有价值的基础。
研究设计与样本
- 研究使用谷氨酰胺合成酶双敲除杜氏利什曼原虫活减毒株(LdGS-/-),以极低接种量单剂免疫BALB/c小鼠,随后以野生型LdGS+/+进行强毒攻击。
主要发现
- LdGS-/-免疫组在强毒攻击后早至2周即产生IFN-γ+ Th1介导免疫。
- LdGS-/-免疫组脾脏中CD4+ T效应细胞与T记忆细胞分化,提供针对野生型LdGS+/+感染的长期记忆保护。
- LdGS-/-免疫并野生型攻击组在攻击后第8周促炎及记忆诱导与维持细胞因子表达仍较高;而相同数量LdGS+/+免疫并野生型攻击组这些细胞因子无显著升高。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Visceral leishmaniasis (VL) is a major threat to economically challenged sectors of the world, and there are only limited options in vaccines available at present. Vaccination using live attenuated strains is preferred for their retention of true antigens, however, the major concern about these vaccines is raised by their ability to protect from virulent challenge at the early time point and also bearing the risk of a potential outbreak of their own. In this study, we reported a metabolically deficient glutamine synthetase double knock-out live attenuated strain of Leishmania donovani (LdGS-/-) that, with a very low inoculum single dose, is highly effective in generating an IFN-γ+ Th1-mediated immunity during virulent challenge as early as 2 weeks post-challenge time point. Additionally, at this early time point, immunization with these mutant parasites also led to the differentiation of CD4+ T effector and T memory cells in the spleens of BALB/c mice, providing long-term memory cell based protection from virulent LdGS+/+ (wild type) infection. The levels of expression of pro-inflammatory and T memory inducing and maintenance cytokines were also found to be higher in animals immunized with LdGS-/- parasites and challenged with the wild type parasites at even as high as the 8th week post-challenge. In contrast, there was no significant increase in these cytokines when immunized with the same number of LdGS+/+ and challenged with wild type parasites. Hence, our findings present that LdGS-/- parasites are novel and valuable for designing a potential live attenuated vaccine candidate against the virulent infection of L. donovani.
引用
- Ghosh S, Roy K, Kumar V, et al. Immunization with glutamine synthetase-deficient live attenuated parasites induces the differentiation of memory T cells to protect hosts from virulent infection of Leishmania donovani. Vaccine. 2025. PMID: 40669252. doi:10.1016/j.vaccine.2025.127502
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。